Compare IRM & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | TEVA |
|---|---|---|
| Founded | 1951 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9B | 39.2B |
| IPO Year | 1997 | N/A |
| Metric | IRM | TEVA |
|---|---|---|
| Price | $127.83 | $31.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $122.50 | $38.63 |
| AVG Volume (30 Days) | 1.1M | ★ 5.0M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $4,491,531,000.00 | N/A |
| Revenue This Year | $13.30 | N/A |
| Revenue Next Year | $9.31 | $2.97 |
| P/E Ratio | $267.30 | ★ $28.19 |
| Revenue Growth | ★ 8.30 | N/A |
| 52 Week Low | $77.77 | $14.99 |
| 52 Week High | $134.09 | $37.35 |
| Indicator | IRM | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.46 | 36.66 |
| Support Level | $122.22 | $30.53 |
| Resistance Level | $132.41 | $32.74 |
| Average True Range (ATR) | 3.52 | 1.16 |
| MACD | -0.28 | -0.30 |
| Stochastic Oscillator | 65.15 | 13.48 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.